The price of Aurora Cannabis Inc. (NASDAQ: ACB) closed at $0.59 in the last session, down -3.56% from day before closing price of $0.62. In other words, the price has decreased by -$0.0219 from its previous closing price. On the day, 2497699 shares were traded. ACB stock price reached its highest trading level at $0.6137 during the session, while it also had its lowest trading level at $0.5870.
Unlock the Hottest Top 10 Penny Stocks Today! Discover Now
Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.
Gain Access to Top 10 Penny Stocks Now!.
We take a closer look at ACB’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 3.20 and its Current Ratio is at 4.10. In the meantime, Its Debt-to-Equity ratio is 0.40 whereas as Long-Term Debt/Eq ratio is at 0.35.
Upgrades & Downgrades
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ACB now has a Market Capitalization of 200.06M and an Enterprise Value of 176.00M. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.19 while its Price-to-Book (P/B) ratio in mrq is 0.35. Its current Enterprise Value per Revenue stands at 0.83 whereas that against EBITDA is -0.11.
Stock Price History:
The Beta on a monthly basis for ACB is 2.97, which has changed by -78.24% over the last 52 weeks, in comparison to a change of 1.41% over the same period for the S&P500. Over the past 52 weeks, ACB has reached a high of $2.80, while it has fallen to a 52-week low of $0.55. The 50-Day Moving Average of the stock is 0.6429, while the 200-Day Moving Average is calculated to be 1.0460.
According to the various share statistics, ACB traded on average about 3.48M shares per day over the past 3-months and 3.36M shares per day over the past 10 days. A total of 326.45M shares are outstanding, with a floating share count of 299.83M. Insiders hold about 0.06% of the company’s shares, while institutions hold 17.37% stake in the company. Shares short for ACB as of Apr 27, 2023 were 31.39M with a Short Ratio of 31.39M, compared to 31.14M on Mar 30, 2023.
The company has 5 analysts who recommend its stock at the moment. On average, analysts expect EPS of -$0.05 for the current quarter, with a high estimate of -$0.01 and a low estimate of -$0.07, while EPS last year was -$3.63. The consensus estimate for the next quarter is -$0.06, with high estimates of -$0.04 and low estimates of -$0.07.
Analysts are recommending an EPS of between -$0.14 and -$0.36 for the fiscal current year, implying an average EPS of -$0.28. EPS for the following year is -$0.17, with 8 analysts recommending between -$0.07 and -$0.29.
According to 8 analysts, the current quarter’s revenue is expected to be $48.21M. It ranges from a high estimate of $50M to a low estimate of $43.39M. As of the current estimate, Aurora Cannabis Inc.’s year-ago sales were $37.83M, an estimated increase of 27.50% from the year-ago figure. For the next quarter, 2 analysts are estimating revenue of $47.5M, an increase of 26.60% less than the figure of $27.50% in the same quarter last year. There is a high estimate of $48.13M for the next quarter, whereas the lowest estimate is $46.87M.
A total of 10 analysts have provided revenue estimates for ACB’s current fiscal year. The highest revenue estimate was $200.62M, while the lowest revenue estimate was $127.07M, resulting in an average revenue estimate of $146.57M. In the same quarter a year ago, actual revenue was $165.43M, down -11.40% from the average estimate. Based on 9 analysts’ estimates, the company’s revenue will be $203.84M in the next fiscal year. The high estimate is $242.04M and the low estimate is $187.35M. The average revenue growth estimate for next year is up 39.10% from the average revenue estimate for this year.